21.97
-1.69 (-7.12%)
| Penutupan Terdahulu | 23.65 |
| Buka | 23.73 |
| Jumlah Dagangan | 4,801,158 |
| Purata Dagangan (3B) | 5,315,828 |
| Modal Pasaran | 10,970,409,984 |
| Harga / Pendapatan (P/E Ke hadapan) | 20.79 |
| Harga / Jualan (P/S) | 2.36 |
| Harga / Buku (P/B) | 1.71 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 6 Aug 2026 |
| Margin Keuntungan | 8.43% |
| Margin Operasi (TTM) | 10.14% |
| EPS Cair (TTM) | 0.750 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -1.00% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | 109.40% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 69.18% |
| Nisbah Semasa (MRQ) | 2.71 |
| Aliran Tunai Operasi (OCF TTM) | 535.00 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 1.32 B |
| Pulangan Atas Aset (ROA TTM) | 1.14% |
| Pulangan Atas Ekuiti (ROE TTM) | 6.01% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Drug Manufacturers - Specialty & Generic (US) | Bercampur | Menaik |
| Drug Manufacturers - Specialty & Generic (Global) | Bercampur | Menaik | |
| Stok | Elanco Animal Health Incorporat | Menaik | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | 3.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | 3.0 |
| Purata | 1.63 |
|
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production. |
|
| Sektor | Healthcare |
| Industri | Drug Manufacturers - Specialty & Generic |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 1.03% |
| % Dimiliki oleh Institusi | 101.48% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 30.00 (Leerink Partners, 36.58%) | Beli |
| Median | 28.50 (29.75%) | |
| Rendah | 24.00 (Morgan Stanley, 9.27%) | Pegang |
| Purata | 27.75 (26.34%) | |
| Jumlah | 3 Beli, 1 Pegang | |
| Harga Purata @ Panggilan | 26.32 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Keybanc | 25 Feb 2026 | 29.00 (32.03%) | Beli | 26.84 |
| Morgan Stanley | 25 Feb 2026 | 24.00 (9.26%) | Pegang | 26.84 |
| Leerink Partners | 24 Feb 2026 | 30.00 (36.58%) | Beli | 26.38 |
| JP Morgan | 19 Feb 2026 | 28.00 (27.48%) | Beli | 25.20 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |